Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Suggested Use: As a dietary supplement, take one vegan capsule per day with food and water
References MedlinePlus
Anecdotal reports claim that microdosing GLP-1 drugs is more cost-effective and may still offer benefits similar to those of full-dose versions of the medication, such as weight and blood sugar management
For people with low vitamin B12 levels, the answer is yes
This delay in impairment is striking because many drivers would assume they are sober enough to drive as their BAC begins to drop